(NP (NP Oxidoreductive/JJ regulation/NN) (PP of/IN (NP nuclear/JJ factor/NN kappa/NN B/NN)) ./.)
(NP (NP Involvement/NN) (PP of/IN (NP a/DT cellular/JJ reducing/NN catalyst/NN thioredoxin/NN)) ./.)
(S (NP-SBJ-14 We/PRP) (VP have/VBP (VP investigated/VBN (NP (NP an/DT oxidoreductive/JJ regulatory/JJ pathway/NN) (PP for/IN (NP (NP the/DT DNA/NN binding/NN activity/NN) (PP of/IN (NP (NP a/DT pleiotropic/JJ cellular/JJ transcription/NN factor/NN) ,/, (NP (NP nuclear/JJ factor/NN kappa/NN B/NN) (PRN -LRB-/-LRB- (NP NF/NN kappa/NN B/NN) -RRB-/-RRB-)) ,/,))))) has/VBZ been/VBN investigated/VBN (PP by/IN (S (NP-SBJ *-14/-NONE-) (VP using/VBG (NP (NP NF/NN kappa/NN B/NN) (VP prepared/VBN (NP */-NONE-) (PP from/IN (NP (NP-COOD (NP the/DT nucleus/NN) and/CC (NP the/DT cytosol/NN)) (PP of/IN (NP the/DT primary/JJ human/JJ T/NN lymphocytes/NNS))))))))))) ./.)
(S (NP-SBJ We/PRP) (VP show/VBP (SBAR that/IN (S (NP-SBJ a/DT cellular/JJ reducing/NN catalyst/NN (NP (NP thioredoxin/NN) (PRN -LRB-/-LRB- (NP Trx/NN) -RRB-/-RRB-))) (VP plays/VBZ (NP a/DT major/JJ role/NN) (PP in/IN (NP-COOD (NP (NP activation/NN) (PP of/IN (NP (NP the/DT DNA/NN binding/NN) (PP of/IN (NP NF/NN kappa/NN B/NN)) (ADVP in/FW vitro/FW)))) and/CC (NP (NP stimulation/NN) (PP of/IN (NP (NP transcription/NN) (PP from/IN (NP the/DT (ADJP NF/NN kappa/NN B-dependent/JJ) gene/NN expression/NN))))))))))) ./.)
(S (NP-SBJ We/PRP) (VP demonstrate/VBP (NP (NP evidence/NN) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ-15 (NP redox/NN regulation/NN) (PP of/IN (NP NF/NN kappa/NN B/NN)) (PP by/IN (NP Trx/NN))) (VP might/MD (VP be/VB (VP exerted/VBN (NP *-15/-NONE-) (PP-TMP at/IN (NP (NP a/DT step/NN) (PP-TMP after/IN (NP (NP dissociation/NN) (PP of/IN (NP (NP the/DT inhibitory/JJ molecule/NN I/NN kappa/NN B/NN) ,/, (NP (NP a/DT cytosolic-anchoring/JJ protein/NN) (PP for/IN (NP NF/NN kappa/NN B/NN))))))))))))))))) ./.)
(S (S (NP-SBJ *-16/-NONE-) (VP To/TO (VP examine/VB (NP (NP the/DT effect/NN) (PP of/IN (NP Trx/NN)) (PP in/IN (NP intact/JJ cells/NNS)))))) ,/, (NP-SBJ-16 we/PRP) (VP performed/VBD (NP transient/JJ assay/NN) (PP with/IN (NP-COOD (NP (NP a/DT (ADJP chloramphenicol/NN acetyltransferase-expressing/JJ) plasmid/NN) (PP under/IN (NP (NP the/DT control/NN) (PP of/IN (NP (NP (NP human/JJ immunodeficiency/NN virus/NN) (PRN -LRB-/-LRB- (NP HIV/NN) -RRB-/-RRB-)) long/JJ terminal/JJ repeat/NN))))) and/CC (NP (NP an/DT effector/NN plasmid/NN) (VP expressing/VBG (NP human/JJ Trx/NN)))))) ./.)
(S (NP-SBJ-17 (NP The/DT promoter/NN activity/NN) (PP from/IN (NP HIV/NN long/JJ terminal/JJ repeat/NN))) (VP was/VBD (VP (ADVP greatly/RB) augmented/VBN (NP *-17/-NONE-) (PP by/IN (S-LGS (NP-SBJ */-NONE-) (VP co-transfecting/VBG (NP (NP the/DT Trx-expressing/NN plasmid/NN) ,/, (SBAR (WHNP-18 whose/WP$ effect/NN) (S (NP-SBJ *T*-18/-NONE-) (VP was/VBD (ADJP-PRD dependent/JJ (PP on/IN (NP the/DT (ADJP NF/NN kappa/NN B-binding/NN) sites/NNS)))))))))))) ./.)
(S (NP-SBJ These/DT findings/NNS) (VP have/VBP (VP suggested/VBN (SBAR-COOD (SBAR that/IN (S (NP-SBJ-20 (NP cysteine/NN residue/NN -LRB-/-LRB- s/NNS -RRB-/-RRB-) (PP of/IN (NP NF/NN kappa/NN B/NN))) (VP might/MD (VP be/VB (VP involved/VBN (NP *-20/-NONE-) (PP in/IN (NP (NP the/DT DNA-recognition/NN) (PP by/IN (NP NF/NN kappa/NN B/NN))))))))) and/CC (SBAR that/IN (S (NP-SBJ (NP the/DT redox/NN control/NN mechanism/NN) (VP mediated/VBN (NP */-NONE-) (PP by/IN (NP-LGS Trx/NN)))) (VP might/MD (VP have/VB (NP a/DT regulatory/JJ role/NN) (PP in/IN (NP the/DT (ADJP NF/NN kappa/NN B-mediated/JJ) gene/NN expression/NN))))))))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP may/MD (ADVP also/RB) (VP provide/VB (NP (NP a/DT clue/NN) (PP to/TO (NP (NP understanding/NN) (PP of/IN (NP (NP the/DT molecular/JJ process/NN) (PP of/IN (NP-COOD (NP AIDS/NN pathogenesis/NN) and/CC (NP its/PRP$ possible/JJ biochemical/JJ intervention/NN)))))))))) ./.)
